186 related articles for article (PubMed ID: 27363651)
1. Protective effects of naringenin in cardiorenal syndrome.
Liu Y; An W; Gao A
J Surg Res; 2016 Jun; 203(2):416-23. PubMed ID: 27363651
[TBL] [Abstract][Full Text] [Related]
2. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.
Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of valsartan and benazepril combined with atorvastatin on cardiorenal syndrome in rats.
Tang SY; Peng DF; Hu YJ; Chen J
Eur Rev Med Pharmacol Sci; 2015; 19(5):759-66. PubMed ID: 25807427
[TBL] [Abstract][Full Text] [Related]
4. Qiliqiangxin Protects against Renal Injury in Rat with Cardiorenal Syndrome Type I through Regulating the Inflammatory and Oxidative Stress Signaling.
Duan X; Yan F; Hu H; Liu H; Wu Q; Sun S; Ming X; Bu X; He Y; Zhu H
Biol Pharm Bull; 2018; 41(8):1178-1185. PubMed ID: 30068867
[TBL] [Abstract][Full Text] [Related]
5. Entresto protected the cardiomyocytes and preserved heart function in cardiorenal syndrome rat fed with high-protein diet through regulating the oxidative stress and Mfn2-mediated mitochondrial functional integrity.
Yeh JN; Yue Y; Chu YC; Huang CR; Yang CC; Chiang JY; Yip HK; Guo J
Biomed Pharmacother; 2021 Dec; 144():112244. PubMed ID: 34601193
[TBL] [Abstract][Full Text] [Related]
6. Higenamine Improves Cardiac and Renal Fibrosis in Rats With Cardiorenal Syndrome via ASK1 Signaling Pathway.
Deng T; Wei Z; Gael A; Deng X; Liu Y; Lai J; Hang L; Yan Q; Fu Q; Li Z
J Cardiovasc Pharmacol; 2020 Jun; 75(6):535-544. PubMed ID: 32168151
[TBL] [Abstract][Full Text] [Related]
7. [The effect of nuclear factor erythroid-2-related factor2 on the changes of cardiac function and electrocardiogram in rats after exhausted exercise].
Xu P; Kang T; Liu HY; Sun WW; Xie YN; Cao XB
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Feb; 32(2):146-151. PubMed ID: 29931867
[TBL] [Abstract][Full Text] [Related]
8. Naringenin protects against cadmium-induced oxidative renal dysfunction in rats.
Renugadevi J; Prabu SM
Toxicology; 2009 Feb; 256(1-2):128-34. PubMed ID: 19063931
[TBL] [Abstract][Full Text] [Related]
9. Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: implications for cardiorenal syndrome.
Liu S; Kompa AR; Kumfu S; Nishijima F; Kelly DJ; Krum H; Wang BH
Int J Cardiol; 2013 Oct; 168(3):1866-80. PubMed ID: 23347614
[TBL] [Abstract][Full Text] [Related]
10. The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome.
Chua S; Lee FY; Chiang HJ; Chen KH; Lu HI; Chen YT; Yang CC; Lin KC; Chen YL; Kao GS; Chen CH; Chang HW; Yip HK
J Pineal Res; 2016 Nov; 61(4):438-456. PubMed ID: 27465663
[TBL] [Abstract][Full Text] [Related]
11. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of Benzo[a]pyrene-induced oxidative stress and pulmonary toxicity by Naringenin in Wistar rats: A plausible role of COX-2 and NF-κB.
Ali R; Shahid A; Ali N; Hasan SK; Majed F; Sultana S
Hum Exp Toxicol; 2017 Apr; 36(4):349-364. PubMed ID: 27206700
[TBL] [Abstract][Full Text] [Related]
13. Recombinant
Liu X; Niu Y; Zhang X; Zhang Y; Yu Y; Huang J; Li J; Yu C
Anal Cell Pathol (Amst); 2019; 2019():5853426. PubMed ID: 31309036
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic impact of entresto on protecting against cardiorenal syndrome-associated renal damage in rats on high protein diet.
Yang CC; Chen YT; Chen CH; Li YC; Shao PL; Huang TH; Chen YL; Sun CK; Yip HK
Biomed Pharmacother; 2019 Aug; 116():108954. PubMed ID: 31108352
[TBL] [Abstract][Full Text] [Related]
15. Allicin ameliorates cardiac hypertrophy and fibrosis through enhancing of Nrf2 antioxidant signaling pathways.
Li XH; Li CY; Xiang ZG; Hu JJ; Lu JM; Tian RB; Jia W
Cardiovasc Drugs Ther; 2012 Dec; 26(6):457-65. PubMed ID: 22990325
[TBL] [Abstract][Full Text] [Related]
16. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
[TBL] [Abstract][Full Text] [Related]
17. Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal Syndrome.
Giam B; Kaye DM; Rajapakse NW
Heart Lung Circ; 2016 Aug; 25(8):874-80. PubMed ID: 27132623
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of cardiac function changes in rat models of Sjogren's syndrome based on Keap1-Nrf2/ARE signaling pathways].
Wang F; Liu J; Ye Y; Zhang X; Wan L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):497-501. PubMed ID: 24796746
[TBL] [Abstract][Full Text] [Related]
19. Valsartan attenuates cardiac and renal hypertrophy in rats with experimental cardiorenal syndrome possibly through down-regulating galectin-3 signaling.
Zhang MJ; Gu Y; Wang H; Zhu PF; Liu XY; Wu J
Eur Rev Med Pharmacol Sci; 2016; 20(2):345-54. PubMed ID: 26875907
[TBL] [Abstract][Full Text] [Related]
20. Polyphenol-Rich Fraction of Parquetina nigrescens Mitigates Dichlorvos-Induced Cardiorenal Dysfunction Through Reduction in Cardiac Nitrotyrosine and Renal p38 Expressions in Wistar Rats.
Oyagbemi AA; Omobowale TO; Ochigbo GO; Asenuga ER; Ola-Davies OE; Ajibade TO; Saba AB; Adedapo AA
J Diet Suppl; 2018 May; 15(3):269-284. PubMed ID: 28800275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
